Davis AS, Viera AJ, Mead MD. Leukemia: an overview for primary care. Am Fam Physician. 2014;89(9):731–8.

PubMed  Google Scholar 

Dong Y, Shi O, Zeng Q, Lu X, Wang W, Li Y, et al. Leukemia incidence trends at the global, regional, and national level between 1990 and 2017. Exp Hematol Oncol. 2020;9(1):14.

Article  PubMed  PubMed Central  Google Scholar 

Chakraborty S, Park CY. Pathogenic mechanisms in acute myeloid leukemia. Curr Treat Options Oncol. 2022;23(11):1522–34.

Article  PubMed  Google Scholar 

Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBdO, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720–48.

Article  PubMed  PubMed Central  Google Scholar 

Peña-Romero AC, Orenes-Piñero E. Dual effect of immune cells within tumour microenvironment: pro- and anti-tumour effects and their triggers. Cancers. 2022;14(7):1681.

Article  PubMed  PubMed Central  Google Scholar 

Curran EK, Godfrey J, Kline J. Mechanisms of immune tolerance in leukemia and lymphoma. Trends Immunol. 2017;38(7):513–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Whiteley AE, Price TT, Cantelli G, Sipkins DA. Leukaemia: a model metastatic disease. Nat Rev Cancer. 2021;21(7):461–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Döhner H, Wei AH, Löwenberg B. Towards precision medicine for AML. Nat Rev Clin Oncol. 2021;18(9):577–90.

Article  PubMed  Google Scholar 

Ci T, Zhang W, Qiao Y, Li H, Zang J, Li H, et al. Delivery strategies in treatments of leukemia. Chem Soc Rev. 2022;51(6):2121–44.

Article  CAS  PubMed  Google Scholar 

Li F, Wang H, Ye T, Guo P, Lin X, Hu Y, et al. Recent advances in material technology for leukemia treatments. Adv Mater. 2024;36(26):2313955.

Article  CAS  Google Scholar 

Wan Z, Sun R, Moharil P, Chen J, Liu Y, Song X, et al. Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia. J Leukoc Biol. 2020;109(2):425–36.

Article  PubMed  Google Scholar 

Holstein SA, Lunning MA. CAR T-cell therapy in hematologic malignancies: a voyage in progress. Clin Pharmacol Ther. 2020;107(1):112–22.

Article  CAS  PubMed  Google Scholar 

Miles LA, Bowman RL, Merlinsky TR, Csete IS, Ooi AT, Durruthy-Durruthy R, et al. Single-cell mutation analysis of clonal evolution in myeloid malignancies. Nature. 2020;587(7834):477–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morita K, Wang F, Jahn K, Hu T, Tanaka T, Sasaki Y, et al. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nat Commun. 2020;11(1):5327.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burd A, Levine RL, Ruppert AS, Mims AS, Borate U, Stein EM, et al. Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial. Nat Med. 2020;26(12):1852–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosenzweig SA. Acquired resistance to drugs targeting receptor tyrosine kinases. Biochem Pharmacol. 2012;83(8):1041–8.

Article  CAS  PubMed  Google Scholar 

Dacoba TG, Olivera A, Torres D, Crecente-Campo J, Alonso MJ. Modulating the immune system through nanotechnology. Semin Immunol. 2017;34:78–102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim CK, Ghosh P, Pagliuca C, Zhu Z-J, Menichetti S, Rotello VM. Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells. J Am Chem Soc. 2009;131(4):1360–1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang X, Li J, Wang Y, Koenig L, Gjyrezi A, Giannakakou P, et al. A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model. ACS Nano. 2011;5(8):6184–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jurj A, Braicu C, Pop LA, Tomuleasa C, Gherman CD, Berindan-Neagoe I. The new era of nanotechnology, an alternative to change cancer treatment. Drug Des Dev Ther. 2017;11:2871–90.

Article  CAS  Google Scholar 

Tomuleasa C, Braicu C, Irimie A, Craciun L, Berindan-Neagoe I. Nanopharmacology in translational hematology and oncology. Int J Nanomed. 2014;9:3465–79.

CAS  Google Scholar 

Kim PS, Djazayeri S, Zeineldin R. Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer. Gynecol Oncol. 2011;120(3):393–403.

Article  PubMed  Google Scholar 

Ajnai G, Chiu A, Kan T, Cheng C-C, Tsai T-H, Chang J. Trends of gold nanoparticle-based drug delivery system in cancer therapy. J Exp Clin Med. 2014;6(6):172–8.

Article  CAS  Google Scholar 

Jain K, Mehra NK, Jain NK. Potentials and emerging trends in nanopharmacology. Curr Opin Pharmacol. 2014;15:97–106.

Article  CAS  PubMed  Google Scholar 

Qian S, Zheng C, Wu Y, Huang H, Wu G, Zhang J. Targeted therapy for leukemia based on nanomaterials. Heliyon. 2024;10(15):e34951.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomed. 2015;10:975–99.

Article  CAS  Google Scholar 

Rajabi L, Ebrahimdoost M, Mohammadi SA, Soleimani Samarkhazan H, Khamisipour G, Aghaei M. Aqueous and ethanolic extracts of Moringa oleifera leaves induce selective cytotoxicity in Raji and Jurkat cell lines by activating the P21 pathway independent of P53. Mol Biol Rep. 2025;52(1):102.

Article  CAS  PubMed  Google Scholar 

Mi J, Ye Q, Min Y. Advances in nanotechnology development to overcome current roadblocks in CAR-T therapy for solid tumors. Front Immunol. 2022;13: 849759.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2008;14(5):1310–6.

Article  CAS  Google Scholar 

Deng M, Yuan H, Liu S, Hu Z, Xiao H. Exosome-transmitted LINC00461 promotes multiple myeloma cell proliferation and suppresses apoptosis by modulating microRNA/BCL-2 expression. Cytotherapy. 2019;21(1):96–106.

Article  CAS  PubMed  Google Scholar 

Georgeous J, AlSawaftah N, Abuwatfa WH, Husseini GA. Review of gold nanoparticles: synthesis, properties, shapes, cellular uptake, targeting, release mechanisms and applications in drug delivery and therapy. Pharmaceutics. 2024;16(10):1332.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lang X, Wang X, Han M, Guo Y. Nanoparticle-mediated synergistic chemoimmunotherapy for cancer treatment. Int J Nanomed. 2024;19:4533–68.

Article